| A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19 DR Boulware, MF Pullen, AS Bangdiwala, KA Pastick, SM Lofgren, ... New England journal of medicine 383 (6), 517-525, 2020 | 1631 | 2020 |
| Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial CP Skipper, KA Pastick, NW Engen, AS Bangdiwala, M Abassi, ... Annals of internal medicine 173 (8), 623-631, 2020 | 677 | 2020 |
| Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19) KA Pastick, EC Okafor, F Wang, SM Lofgren, CP Skipper, MR Nicol, ... Open forum infectious diseases 7 (4), ofaa130, 2020 | 258 | 2020 |
| Hydroxychloroquine as pre-exposure prophylaxis for coronavirus disease 2019 (COVID-19) in healthcare workers: a randomized trial R Rajasingham, AS Bangdiwala, MR Nicol, CP Skipper, KA Pastick, ... Clinical Infectious Diseases 72 (11), e835-e843, 2021 | 172 | 2021 |
| Evaluation of a dried blood spot HIV-1 RNA program for early infant diagnosis and viral load monitoring at rural and remote healthcare facilities SM Lofgren, AB Morrissey, CC Chevallier, AI Malabeja, S Edmonds, ... Aids 23 (18), 2459-2466, 2009 | 128 | 2009 |
| Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial J Rhein, KH Hullsiek, L Tugume, E Nuwagira, E Mpoza, EE Evans, ... The Lancet infectious diseases 19 (8), 843-851, 2019 | 119 | 2019 |
| Burden of depression in outpatient HIV-infected adults in sub-Saharan Africa; systematic review and meta-analysis SM Lofgren, DJ Bond, N Nakasujja, DR Boulware AIDS and Behavior 24 (6), 1752-1764, 2020 | 81 | 2020 |
| Symptoms of COVID-19 outpatients in the United States MF Pullen, CP Skipper, KH Hullsiek, AS Bangdiwala, KA Pastick, ... Open forum infectious diseases 7 (7), ofaa271, 2020 | 80 | 2020 |
| Safety of hydroxychloroquine among outpatient clinical trial participants for COVID-19 SM Lofgren, MR Nicol, AS Bangdiwala, KA Pastick, EC Okafor, ... Open forum infectious diseases 7 (11), ofaa500, 2020 | 57 | 2020 |
| HIV-associated cryptococcal meningitis occurring at relatively higher CD4 counts L Tugume, J Rhein, KH Hullsiek, E Mpoza, R Kiggundu, ... The Journal of infectious diseases 219 (6), 877-883, 2019 | 57 | 2019 |
| Histoplasmosis among hospitalized febrile patients in northern Tanzania SM Lofgren, EJ Kirsch, VP Maro, AB Morrissey, LJ Msuya, GD Kinabo, ... Transactions of the Royal Society of Tropical Medicine and Hygiene 106 (8 …, 2012 | 54 | 2012 |
| Systematic review of interventions for depression for people living with HIV in Africa SM Lofgren, N Nakasujja, DR Boulware AIDS and Behavior 22, 1-8, 2018 | 45 | 2018 |
| Symptomatic cryptococcal antigenemia presenting as early cryptococcal meningitis with negative cerebral spinal fluid analysis K Ssebambulidde, AS Bangdiwala, R Kwizera, TK Kandole, L Tugume, ... Clinical infectious diseases 68 (12), 2094-2098, 2019 | 38 | 2019 |
| A prospective evaluation of a multisite cryptococcal screening and treatment program in HIV clinics in Uganda E Nalintya, DB Meya, S Lofgren, KH Hullsiek, DR Boulware, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 78 (2), 231-238, 2018 | 37 | 2018 |
| Cytomegalovirus viremia associated with increased mortality in cryptococcal meningitis in Sub-Saharan Africa C Skipper, MR Schleiss, AS Bangdiwala, N Hernandez-Alvarado, ... Clinical Infectious Diseases 71 (3), 525-531, 2020 | 32 | 2020 |
| Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial SA Lother, M Abassi, A Agostinis, AS Bangdiwala, MP Cheng, G Drobot, ... Canadian Journal of Anaesthesia 67 (9), 1201, 2020 | 31 | 2020 |
| Differences in immunologic factors among patients presenting with altered mental status during cryptococcal meningitis S Lofgren, KH Hullsiek, BM Morawski, HW Nabeta, R Kiggundu, ... The Journal of infectious diseases 215 (5), 693-697, 2017 | 25 | 2017 |
| Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings S Lofgren, M Abassi, J Rhein, DR Boulware Expert review of anti-infective therapy 15 (4), 331-340, 2017 | 24 | 2017 |
| Heterogeneity in neurocognitive change trajectories among people with HIV starting antiretroviral therapy in Rakai, Uganda LH Rubin, D Saylor, G Nakigozi, N Nakasujja, K Robertson, A Kisakye, ... Journal of neurovirology 25, 800-813, 2019 | 20 | 2019 |
| Barriers to HIV care in Uganda and implications for universal test-and-treat: a qualitative study SM Lofgren, S Tsui, L Atuyambe, L Ankunda, R Komuhendo, N Wamala, ... AIDS care 34 (5), 597-605, 2022 | 18 | 2022 |
David MeyaAssociate Professor, College of Health Sciences, Makerere University; Adjunct Associate ProfessorVerified email at mak.ac.ug
